Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

XTL Biopharmaceuticals Notified Regarding Minimum Bid Requirements

By XTL Biopharmaceuticals Ltd. | November 10, 2016

XTL Biopharmaceuticals receives NASDAQ notification regarding minimum bid requirements.

XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company developing its lead product for the treatment of autoimmune diseases, announced that it received a notice from The NASDAQ Stock Market that the company is not in compliance with NASDAQ’s Listing Rule 5450(a)(1) because the minimum bid price of the company’s American Depositary Shares (ADSs) has closed below $1 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the company’s ADSs on The Nasdaq Capital Market.

The company has 180 days, or until May 8, 2017, to achieve compliance with the minimum bid price requirement. To regain compliance, the minimum bid price of the company’s ADSs must meet or exceed $1 per share for a minimum of 10 consecutive business days during this 180-day grace period.

If the company does not regain compliance with the rule by May 8, 2017, the company may be eligible for an additional 180 day compliance period.

(Source: PR Newswire)

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE